Target intelligence / Profile preview

Reactive oxygen species (ROS) and redox-sensitive signaling pathway (ROS)

Target
ROS
Molecular classification
Other, Signaling pathway
01

Overview

Reactive oxygen species (ROS) are highly reactive molecules derived from oxygen, such as superoxide and hydrogen peroxide, which function as critical signaling molecules in physiological processes including cell proliferation and immune defense (Sies et al., 2017). Under normal conditions, redox-sensitive signaling pathways maintain cellular homeostasis by balancing ROS production with antioxidant defenses. However, an excess of ROS leads to oxidative stress, causing oxidative damage to DNA, proteins, and lipids, which is implicated in the pathogenesis of cancer, neurodegenerative diseases, and cardiovascular disorders (Finkel & Holbrook, 2000). Drugs targeting these pathways often exhibit non-specific antioxidant activity by directly scavenging free radicals or inducing endogenous antioxidant enzymes like superoxide dismutase (Halliwell, 2011). While these agents, such as N-acetylcysteine and Vitamin C, are used to mitigate oxidative damage, their clinical efficacy is often hampered by the disruption of essential ROS-mediated signaling, a phenomenon known as the "antioxidant paradox" (Gomez-Cabrera et al., 2008). Consequently, this "target" represents a broad biological process rather than a specific molecular entity, making precise pharmacological intervention challenging.

Other names
Oxidative stressRedox signalingReactive oxygen speciesFree radicalsNon-specific antioxidant activity
02

Mechanism of action

Non-specific scavenging of reactive oxygen species and free radicals, and the induction of endogenous antioxidant defense mechanisms to restore redox homeostasis (PubChem, 2024).

03

Biological functions

Signal transductionCell deathApoptosisHomeostasisOxidative stress response
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseAging
05

Safety considerations

Pro-oxidant effects at high concentrationsInterference with physiological ROS signaling required for immune functionPotential reduction in the efficacy of ROS-dependent therapies like radiation or certain chemotherapies (Halliwell, 2011)
06

Interacting drugs

N-acetylcysteine

5 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)Glutathione (GSH/GSSG) ratioSuperoxide dismutase (SOD) activity

Beyond the preview

Go deeper on Reactive oxygen species (ROS) and redox-sensitive signaling pathway (ROS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species (ROS) and redox-sensitive signaling pathway (ROS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call